Definium Therapeutics, Inc. DFTX 深 沪
交易中 10-06 10:12:57 美东时间
36.125
-0.105
-0.29%
华盛通- 最 高45.31
- 今 开36.55
- 成交量 15.04万股
- 最 低 35.5101
- 昨 收 36.23
- 总市值 0
- 52周最高 49.70
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 14.62
- 委 比 -94.17%
- 总股本 --
- 历史最高 49.70
- 量 比 0
- 振 幅 27.05%
- 历史最低 14.62
- 每 手 1
- 风险率 11.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Definium Says Its Anxiety Drug Showed 'Unprecedented Efficacy'
Definium Therapeutics announced positive Phase 3 Panorama trial results for DT120 in generalized anxiety disorder patients.
09-14 23:13
Definium Therapeutics Plans To Commence $500M Common Stock Offering
Definium Therapeutics, Inc. (NASDAQ:DFTX) (the "Company" or "Definium"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes
06-23 04:01
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 points on Monday. The Dow traded up 0.28% to 51,709.06 while the NASDAQ fell 1.31% to 26,170.77. The S&P 500 also
06-23 00:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-market session. The company's market cap stands at $4.0 million. Aditxt (NASDAQ:ADTX) shares rose 84.99% to $0.02.
06-22 20:05
Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst
Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.
04-18 02:06
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
